262 related articles for article (PubMed ID: 33753455)
1. Radium-223 Treatment Increases Immune Checkpoint Expression in Extracellular Vesicles from the Metastatic Prostate Cancer Bone Microenvironment.
Vardaki I; Corn P; Gentile E; Song JH; Madan N; Hoang A; Parikh N; Guerra L; Lee YC; Lin SC; Yu G; Santos E; Melancon MP; Troncoso P; Navone N; Gallick GE; Efstathiou E; Subudhi SK; Lin SH; Logothetis CJ; Panaretakis T
Clin Cancer Res; 2021 Jun; 27(11):3253-3264. PubMed ID: 33753455
[TBL] [Abstract][Full Text] [Related]
2. LncRNA nuclear-enriched abundant transcript 1 shuttled by prostate cancer cells-secreted exosomes initiates osteoblastic phenotypes in the bone metastatic microenvironment via miR-205-5p/runt-related transcription factor 2/splicing factor proline- and glutamine-rich/polypyrimidine tract-binding protein 2 axis.
Mo C; Huang B; Zhuang J; Jiang S; Guo S; Mao X
Clin Transl Med; 2021 Aug; 11(8):e493. PubMed ID: 34459124
[TBL] [Abstract][Full Text] [Related]
3. Exosomal miRNAs from Prostate Cancer Impair Osteoblast Function in Mice.
Furesi G; de Jesus Domingues AM; Alexopoulou D; Dahl A; Hackl M; Schmidt JR; Kalkhof S; Kurth T; Taipaleenmäki H; Conrad S; Hofbauer C; Rauner M; Hofbauer LC
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163219
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer extracellular vesicles mediate intercellular communication with bone marrow cells and promote metastasis in a cholesterol-dependent manner.
Henrich SE; McMahon KM; Plebanek MP; Calvert AE; Feliciano TJ; Parrish S; Tavora F; Mega A; De Souza A; Carneiro BA; Thaxton CS
J Extracell Vesicles; 2020 Dec; 10(2):e12042. PubMed ID: 33408816
[TBL] [Abstract][Full Text] [Related]
5. Role of exosomes in prostate cancer bone metastasis.
Lv T; Li Z; Wang D; Guo X; Zhang X; Cao J; Wang Z
Arch Biochem Biophys; 2023 Oct; 748():109784. PubMed ID: 37816420
[TBL] [Abstract][Full Text] [Related]
6. Evaluating Changes in Immune Function and Bone Microenvironment During Radium-223 Treatment of Patients with Castration-Resistant Prostate Cancer.
Dorff TB; Stein C; Kortylewski M; Posadas E; Synold T; Quinn D
Cancer Biother Radiopharm; 2020 Sep; 35(7):485-489. PubMed ID: 32366119
[TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamic study of radium-223 in men with bone metastatic castration resistant prostate cancer.
Armstrong AJ; Gupta S; Healy P; Kemeny G; Leith B; Zalutsky MR; Spritzer C; Davies C; Rothwell C; Ware K; Somarelli JA; Wood K; Ribar T; Giannakakou P; Zhang J; Gerber D; Anand M; Foo WC; Halabi S; Gregory SG; George DJ
PLoS One; 2019; 14(5):e0216934. PubMed ID: 31136607
[TBL] [Abstract][Full Text] [Related]
8. The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic prostate cancer.
Saylor PJ; Kozin SV; Matsui A; Goldberg SI; Aoki S; Shigeta K; Mamessier E; Smith MR; Michaelson MD; Lee RJ; Duda DG
Radiother Oncol; 2024 Mar; 192():110091. PubMed ID: 38224917
[TBL] [Abstract][Full Text] [Related]
9. Alpha particles as radiopharmaceuticals in the treatment of bone metastases: mechanism of action of radium-223 chloride (Alpharadin) and radiation protection.
Cheetham PJ; Petrylak DP
Oncology (Williston Park); 2012 Apr; 26(4):330-7, 341. PubMed ID: 22655525
[TBL] [Abstract][Full Text] [Related]
10. Combination radium-223 therapies in patients with bone metastases from castration-resistant prostate cancer: A review.
Cursano MC; Iuliani M; Casadei C; Stellato M; Tonini G; Paganelli G; Santini D; De Giorgi U
Crit Rev Oncol Hematol; 2020 Feb; 146():102864. PubMed ID: 31986318
[TBL] [Abstract][Full Text] [Related]
11. Role of Exosomes in Prostate Cancer Metastasis.
Akoto T; Saini S
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805398
[TBL] [Abstract][Full Text] [Related]
12. BHLHE22 drives the immunosuppressive bone tumor microenvironment and associated bone metastasis in prostate cancer.
Yin C; Wang M; Wang Y; Lin Q; Lin K; Du H; Lang C; Dai Y; Peng X
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36941015
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Radium-223 in Bone-metastatic Castration-resistant Prostate Cancer with and Without Homologous Repair Gene Defects.
Isaacsson Velho P; Qazi F; Hassan S; Carducci MA; Denmeade SR; Markowski MC; Thorek DL; DeWeese TL; Song DY; Tran PT; Eisenberger MA; Antonarakis ES
Eur Urol; 2019 Aug; 76(2):170-176. PubMed ID: 30293905
[TBL] [Abstract][Full Text] [Related]
14. Radium 223-Mediated Zonal Cytotoxicity of Prostate Cancer in Bone.
Dondossola E; Casarin S; Paindelli C; De-Juan-Pardo EM; Hutmacher DW; Logothetis CJ; Friedl P
J Natl Cancer Inst; 2019 Oct; 111(10):1042-1050. PubMed ID: 30657953
[TBL] [Abstract][Full Text] [Related]
15. [Principles, modalities and indications of the administration of Radium in cancers, focus on metastatic prostate cancer: State of arts].
Bertolaso P; Leroy L; Gross-Goupil M; Aupee O; Ravaud A; Roubaud G; Cazeau AL; Le Moulec S
Bull Cancer; 2017 Sep; 104(9):762-770. PubMed ID: 28797482
[TBL] [Abstract][Full Text] [Related]
16. Metastatic Prostate Cancer and the Bone: Significance and Therapeutic Options.
Gartrell BA; Coleman R; Efstathiou E; Fizazi K; Logothetis CJ; Smith MR; Sonpavde G; Sartor O; Saad F
Eur Urol; 2015 Nov; 68(5):850-8. PubMed ID: 26153564
[TBL] [Abstract][Full Text] [Related]
17. Radium-223 dichloride for the treatment of metastatic prostate cancer.
Turner PG; O'Sullivan J
Expert Opin Pharmacother; 2014 Oct; 15(14):2105-11. PubMed ID: 25186336
[TBL] [Abstract][Full Text] [Related]
18. Clinical Implications of Exosomal PD-L1 in Cancer Immunotherapy.
Ayala-Mar S; Donoso-Quezada J; González-Valdez J
J Immunol Res; 2021; 2021():8839978. PubMed ID: 33628854
[TBL] [Abstract][Full Text] [Related]
19. Radium-223 in combination with docetaxel in patients with castration-resistant prostate cancer and bone metastases: a phase 1 dose escalation/randomised phase 2a trial.
Morris MJ; Loriot Y; Sweeney CJ; Fizazi K; Ryan CJ; Shevrin DH; Antonarakis ES; Pandit-Taskar N; Deandreis D; Jacene HA; Vesselle H; Petrenciuc O; Lu C; Carrasquillo JA; Higano CS
Eur J Cancer; 2019 Jun; 114():107-116. PubMed ID: 31082669
[TBL] [Abstract][Full Text] [Related]
20. Exosomal mRNAs and lncRNAs involved in multiple myeloma resistance to bortezomib.
Tang JX; Chen Q; Li Q; He YH; Xiao D
Cell Biol Int; 2021 May; 45(5):965-975. PubMed ID: 33372728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]